BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 31341237)

  • 1. Diminished interaction between mutant NOTCH1 and the NuRD corepressor complex upregulates CCL17 in chronic lymphocytic leukemia.
    Wang S; Ge M; Cui J; Qiao Z; Chen X; Wu S; Zhan R; Zhou H; Liu H; Xu Z
    Leukemia; 2019 Dec; 33(12):2951-2956. PubMed ID: 31341237
    [No Abstract]   [Full Text] [Related]  

  • 2. Chronic lymphocytic leukemia cells in lymph nodes show frequent NOTCH1 activation.
    Onaindia A; Gómez S; Piris-Villaespesa M; Martínez-Laperche C; Cereceda L; Montes-Moreno S; Batlle A; de Villambrosia SG; Pollán M; Martín-Acosta P; González-Rincón J; Menarguez J; Alvés J; Rodriguez-Pinilla SM; García JF; Mollejo M; Fraga M; García-Marco JA; Piris MA; Sánchez-Beato M
    Haematologica; 2015 May; 100(5):e200-3. PubMed ID: 25552700
    [No Abstract]   [Full Text] [Related]  

  • 3. Acetylation of histone deacetylase 1 regulates NuRD corepressor complex activity.
    Yang T; Jian W; Luo Y; Fu X; Noguchi C; Bungert J; Huang S; Qiu Y
    J Biol Chem; 2012 Nov; 287(48):40279-91. PubMed ID: 23014989
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Constitutive phosphorylation of the active Notch1 intracellular domain in chronic lymphocytic leukemia cells with NOTCH1 mutation.
    De Falco F; Sabatini R; Falzetti F; Di Ianni M; Sportoletti P; Baldoni S; Del Papa B; Screpanti I; Marconi P; Rosati E
    Leukemia; 2015 Apr; 29(4):994-8. PubMed ID: 25425197
    [No Abstract]   [Full Text] [Related]  

  • 5. Bepridil exhibits anti-leukemic activity associated with NOTCH1 pathway inhibition in chronic lymphocytic leukemia.
    Baldoni S; Del Papa B; Dorillo E; Aureli P; De Falco F; Rompietti C; Sorcini D; Varasano E; Cecchini D; Zei T; Di Tommaso A; Rosati E; Alexe G; Roti G; Stegmaier K; Di Ianni M; Falzetti F; Sportoletti P
    Int J Cancer; 2018 Aug; 143(4):958-970. PubMed ID: 29508386
    [TBL] [Abstract][Full Text] [Related]  

  • 6. NOTCH1-mutated chronic lymphocytic leukemia cells are characterized by a MYC-related overexpression of nucleophosmin 1 and ribosome-associated components.
    Pozzo F; Bittolo T; Vendramini E; Bomben R; Bulian P; Rossi FM; Zucchetto A; Tissino E; Degan M; D'Arena G; Di Raimondo F; Zaja F; Pozzato G; Rossi D; Gaidano G; Del Poeta G; Gattei V; Dal Bo M
    Leukemia; 2017 Nov; 31(11):2407-2415. PubMed ID: 28321119
    [TBL] [Abstract][Full Text] [Related]  

  • 7. NOTCH1 mutational status in chronic lymphocytic leukaemia: clinical relevance of subclonal mutations and mutation types.
    D'Agaro T; Bittolo T; Bravin V; Dal Bo M; Pozzo F; Bulian P; Rossi FM; Zucchetto A; Degan M; D'Arena G; Chiarenza A; Zaja F; Pozzato G; Di Raimondo F; Rossi D; Gaidano G; Del Poeta G; Gattei V; Bomben R
    Br J Haematol; 2018 Aug; 182(4):597-602. PubMed ID: 28699643
    [No Abstract]   [Full Text] [Related]  

  • 8. NOTCH1 mutations are associated with high CD49d expression in chronic lymphocytic leukemia: link between the NOTCH1 and the NF-κB pathways.
    Benedetti D; Tissino E; Pozzo F; Bittolo T; Caldana C; Perini C; Martorelli D; Bravin V; D'Agaro T; Rossi FM; Bomben R; Santinelli E; Zaja F; Pozzato G; Chiarenza A; Di Raimondo F; Del Poeta G; Rossi D; Gaidano G; Dal Bo M; Gattei V; Zucchetto A
    Leukemia; 2018 Mar; 32(3):654-662. PubMed ID: 28935990
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical impact of small subclones harboring NOTCH1, SF3B1 or BIRC3 mutations in chronic lymphocytic leukemia.
    Rasi S; Khiabanian H; Ciardullo C; Terzi-di-Bergamo L; Monti S; Spina V; Bruscaggin A; Cerri M; Deambrogi C; Martuscelli L; Biasi A; Spaccarotella E; De Paoli L; Gattei V; Foà R; Rabadan R; Gaidano G; Rossi D
    Haematologica; 2016 Apr; 101(4):e135-8. PubMed ID: 26819056
    [No Abstract]   [Full Text] [Related]  

  • 10. A Gro/TLE-NuRD corepressor complex facilitates Tbx20-dependent transcriptional repression.
    Kaltenbrun E; Greco TM; Slagle CE; Kennedy LM; Li T; Cristea IM; Conlon FL
    J Proteome Res; 2013 Dec; 12(12):5395-409. PubMed ID: 24024827
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Trisomy 12 chronic lymphocytic leukemia cells exhibit upregulation of integrin signaling that is modulated by NOTCH1 mutations.
    Riches JC; O'Donovan CJ; Kingdon SJ; McClanahan F; Clear AJ; Neuberg DS; Werner L; Croce CM; Ramsay AG; Rassenti LZ; Kipps TJ; Gribben JG
    Blood; 2014 Jun; 123(26):4101-10. PubMed ID: 24829201
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mutations in NOTCH1 PEST domain orchestrate CCL19-driven homing of chronic lymphocytic leukemia cells by modulating the tumor suppressor gene DUSP22.
    Arruga F; Gizdic B; Bologna C; Cignetto S; Buonincontri R; Serra S; Vaisitti T; Gizzi K; Vitale N; Garaffo G; Mereu E; Diop F; Neri F; Incarnato D; Coscia M; Allan J; Piva R; Oliviero S; Furman RR; Rossi D; Gaidano G; Deaglio S
    Leukemia; 2017 Sep; 31(9):1882-1893. PubMed ID: 28017968
    [TBL] [Abstract][Full Text] [Related]  

  • 13. NOTCH1 mutations associate with low CD20 level in chronic lymphocytic leukemia: evidence for a NOTCH1 mutation-driven epigenetic dysregulation.
    Pozzo F; Bittolo T; Arruga F; Bulian P; Macor P; Tissino E; Gizdic B; Rossi FM; Bomben R; Zucchetto A; Benedetti D; Degan M; D'Arena G; Chiarenza A; Zaja F; Pozzato G; Rossi D; Gaidano G; Del Poeta G; Deaglio S; Gattei V; Dal Bo M
    Leukemia; 2016 Jan; 30(1):182-9. PubMed ID: 26165233
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mutations in the 3' untranslated region of
    Bittolo T; Pozzo F; Bomben R; D'Agaro T; Bravin V; Bulian P; Rossi FM; Zucchetto A; Degan M; Macor P; D'Arena G; Chiarenza A; Zaja F; Pozzato G; Di Raimondo F; Rossi D; Gaidano G; Del Poeta G; Gattei V; Dal Bo M
    Haematologica; 2017 Aug; 102(8):e305-e309. PubMed ID: 28550186
    [No Abstract]   [Full Text] [Related]  

  • 15. NOTCH1 mutation in type II Hodgkin transformation of chronic lymphocytic leukemia.
    McGovern B; Quinn F; Andrews C; Jeffers M; Bacon CL; Bird B; Crotty G; Vandenberghe E; Flavin R
    Leuk Lymphoma; 2017 Mar; 58(3):732-735. PubMed ID: 27686521
    [No Abstract]   [Full Text] [Related]  

  • 16. Frequency and clinical relevance of coding and noncoding NOTCH1 mutations in early stage Binet A chronic lymphocytic leukemia patients.
    Lionetti M; Barbieri M; Favasuli V; Taiana E; Fabris S; Favoino C; Ciceri G; Matis S; Colombo M; Massara R; Reda G; Gentile M; Spina V; Rossi D; Baldini L; Gaidano G; Fais F; Ferrarini M; Morabito F; Cutrona G; Neri A
    Hematol Oncol; 2020 Aug; 38(3):406-408. PubMed ID: 32097987
    [No Abstract]   [Full Text] [Related]  

  • 17. Common nonmutational
    Fabbri G; Holmes AB; Viganotti M; Scuoppo C; Belver L; Herranz D; Yan XJ; Kieso Y; Rossi D; Gaidano G; Chiorazzi N; Ferrando AA; Dalla-Favera R
    Proc Natl Acad Sci U S A; 2017 Apr; 114(14):E2911-E2919. PubMed ID: 28314854
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nutlin-3 up-regulates the expression of Notch1 in both myeloid and lymphoid leukemic cells, as part of a negative feedback antiapoptotic mechanism.
    Secchiero P; Melloni E; di Iasio MG; Tiribelli M; Rimondi E; Corallini F; Gattei V; Zauli G
    Blood; 2009 Apr; 113(18):4300-8. PubMed ID: 19190243
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeted next-generation sequencing in chronic lymphocytic leukemia: a high-throughput yet tailored approach will facilitate implementation in a clinical setting.
    Sutton LA; Ljungström V; Mansouri L; Young E; Cortese D; Navrkalova V; Malcikova J; Muggen AF; Trbusek M; Panagiotidis P; Davi F; Belessi C; Langerak AW; Ghia P; Pospisilova S; Stamatopoulos K; Rosenquist R
    Haematologica; 2015 Mar; 100(3):370-6. PubMed ID: 25480502
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activation of the NOTCH1 pathway in chronic lymphocytic leukemia.
    Gianfelici V
    Haematologica; 2012 Mar; 97(3):328-30. PubMed ID: 22383743
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.